Hinge Health (NYSE:HNGE) President Sells $683,550.00 in Stock

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 15,000 shares of the stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $45.57, for a total value of $683,550.00. Following the sale, the president owned 789,902 shares of the company’s stock, valued at $35,995,834.14. This represents a 1.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Hinge Health Price Performance

Hinge Health stock traded up $1.08 during trading hours on Monday, reaching $47.07. The company had a trading volume of 1,715,754 shares, compared to its average volume of 1,186,414. Hinge Health Inc. has a 12-month low of $33.42 and a 12-month high of $62.18. The stock has a 50-day simple moving average of $49.69.

Hinge Health (NYSE:HNGE) last issued its earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.18. The firm had revenue of $154.21 million during the quarter, compared to the consensus estimate of $142.44 million. The business’s revenue for the quarter was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health announced that its Board of Directors has initiated a share repurchase program on Wednesday, November 12th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 7.2% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analyst Weigh In

HNGE has been the topic of a number of research analyst reports. Robert W. Baird began coverage on Hinge Health in a report on Friday, September 5th. They set a “neutral” rating and a $56.00 price target on the stock. Morgan Stanley increased their price target on shares of Hinge Health from $57.00 to $67.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 23rd. Piper Sandler restated an “overweight” rating and issued a $71.00 price objective (up from $70.00) on shares of Hinge Health in a report on Wednesday, November 5th. Weiss Ratings reiterated a “sell (d)” rating on shares of Hinge Health in a report on Wednesday, October 8th. Finally, Wall Street Zen raised Hinge Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Hinge Health has a consensus rating of “Moderate Buy” and an average price target of $59.93.

Hedge Funds Weigh In On Hinge Health

A number of institutional investors and hedge funds have recently made changes to their positions in HNGE. BIT Capital GmbH boosted its position in shares of Hinge Health by 144.6% in the 3rd quarter. BIT Capital GmbH now owns 1,849,524 shares of the company’s stock worth $90,775,000 after purchasing an additional 1,093,320 shares in the last quarter. Bamco Inc. NY purchased a new stake in shares of Hinge Health in the second quarter worth $48,943,000. Braidwell LP bought a new position in shares of Hinge Health during the third quarter valued at $44,686,000. JPMorgan Chase & Co. purchased a new position in shares of Hinge Health in the 2nd quarter worth about $43,840,000. Finally, Franklin Resources Inc. bought a new position in Hinge Health in the 2nd quarter worth about $28,462,000.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.